Health & Wellbeing
Early-stage and high-growth pharma companies, significant research activity in regenerative medicine, sport and exercise medicine, health engineering.
Early-stage and high-growth pharma companies, significant research activity in regenerative medicine, sport and exercise medicine, health engineering.
Loughborough University co-directs the £105 million national hub for world-class rehabilitation research, innovation, education and training, with The University of Nottingham, University Hospitals of Leicester NHS Trust and Nottingham University Hospitals NHS Trust. Pioneering research projects are already underway.
Nemaura Pharma develops cutting-edge innovative drug formulation and medical device technologies designed to radically improve the way drugs are administered through the skin. It was awarded the Frost & Sullivan 2016 Enabling Technology Leadership Award in Transdermal Drug Delivery. Nemaura launched at LUSEP in 2005.
Loughborough University is internationally renowned for driving real-world solutions to promote health and wellbeing for everyone, across the life course. Expertise bridges health and exercise science, psychology, sociology, arts, management, geography, design, engineering and technology. In partnership with clinical and community networks across the Midlands, UK and globally, the University inform policies and deliver far-reaching impact.
From childhood to old age, Loughborough University translates its public health research into practical ways for helping people improve their health across all stages of life.
Based on Loughborough University campus, the NCSEM-EM applies world-class expertise to policies and practise that will benefit the nation’s health and wellbeing of the nation.